What is Basaglar KwikPen?
Basaglar is a brand name for insulin glargine, a long-acting insulin used to treat type 1 and type 2 diabetes [1]. It is designed to provide a basal (background) insulin level over a 24-hour period [1]. The KwikPen is a pre-filled insulin pen device designed for ease of use and accurate dosing [1].
How much does Basaglar KwikPen cost?
The price of Basaglar KwikPen can vary significantly depending on factors such as insurance coverage, pharmacy, and location. Online pharmacies may offer different pricing structures. For instance, some sources list prices ranging from approximately $100 to over $250 for a 5-pen pack [2][3].
What are the savings options for Basaglar KwikPen?
Individuals may be eligible for savings programs or discounts offered by the manufacturer or through insurance plans. Discount cards or coupons can also reduce out-of-pocket expenses [4]. Checking with your insurance provider and the drug manufacturer's website for available assistance programs is recommended.
When does Basaglar patent expire?
Understanding the patent status of Basaglar is important for potential generic or biosimilar competition. Information on drug patents and their expiration dates can be found on resources like DrugPatentWatch.com [5]. The patent landscape for insulin products is complex and can involve multiple patents covering different aspects of the drug and its delivery devices.
How does Basaglar compare to other long-acting insulins?
Basaglar is a biosimilar to Lantus Solostar, another long-acting insulin glargine product [1]. Biosimilars are highly similar to an already approved biological product (the reference product) and have no clinically meaningful differences in terms of safety, purity, and potency [1]. Therefore, Basaglar is intended to offer a comparable therapeutic effect to Lantus. Other long-acting insulins available include insulin detemir (Levemir) and insulin degludec (Tresiba).
What are the potential side effects of Basaglar?
Common side effects of Basaglar, like other insulins, include hypoglycemia (low blood sugar), injection site reactions (redness, swelling, itching), and lipodystrophy (changes in fat tissue at the injection site) [1]. It is crucial to monitor blood sugar levels closely and report any persistent or bothersome side effects to a healthcare provider.
What is the difference between Basaglar and other insulin types?
Basaglar is a long-acting insulin, meaning it is designed to work slowly over many hours to control blood sugar. This contrasts with rapid-acting or short-acting insulins, which are taken before meals to manage post-meal blood sugar spikes. Basaglar provides basal insulin coverage, which is essential for maintaining blood sugar control between meals and overnight.
---
Sources:
[1] https://www.basaglar.com/
[2] https://www.goodrx.com/basaglar
[3] https://www.costplusdrugs.com/medications/insulin-glargine-injection-100units-ml/
[4] https://www.lilydirect.com/search-results?q=basaglar
[5] https://drugpatentwatch.com/